Anti-hyperglycemic effect of vaccinium arctostaphylos in type 2 diabetic patients: A randomized controlled trial

Forschende Komplementarmedizin

Volumn 20, Issue 1, 2013, Pages 17-22

  Kianbakht, Saeed ^a,b   Abasi, Behrooz ^c   Dabaghian, Fataneh Hashem ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c Diabetes Clinic   (Iran)

Author keywords

Patient; Type 2 diabetes; Vaccinium arctostaphylos

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; PLANT EXTRACT;

ADULT; BLOOD; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; DOUBLE BLIND PROCEDURE; DRUG RESISTANCE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IRAN; MALE; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; POSTPRANDIAL STATE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VACCINIUM MYRTILLUS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; DRUG RESISTANCE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; IRAN; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POSTPRANDIAL PERIOD; VACCINIUM MYRTILLUS;

EID: 84924928803     PISSN: 16614119     EISSN: 16614127     Source Type: Journal    
DOI: 10.1159/000346607     Document Type: Article

References (23)

1. Campbell RK: Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. J Am Pharm Assoc 2009;49:S3-S9.
2. Derosa G, Sibilla S: Optimizing combination treatment in the management of type 2 diabetes. Vasc Health Risk Manag 2007;3:665-671.
3. Massi-Benedetti M, Orsini-Federici M: Treatment of type 2 diabetes with combined therapy: what are the pros and cons? Diabetes Care 2008;31: S131-135.
4. Krentz AJ, Bailey CJ: Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005;65:385-411.
5. Huang THW, Kota BP, Razmovski V, Roufogalis BD: Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 2005;96: 3-14.
6. Fugh-Berman A: Herbs and dietary supplements in the prevention and treatment of cardiovascular disease. Prev Cardiol 2000;3:24-32.
7. Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE: Health benefits of herbs and spices: the past, the present, the future. Med J Aust 2006;185:S4-S24.
8. Low Dog T: A reason to season: the therapeutic benefits of spices and culinary herbs. Explore (NY) 2006;2:446-449.
9. Tundis R, Loizzo MR, Menichini F: Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycemic potential in the treatment of diabetes: an update. Mini Rev Med Chem 2010;10:315-331.
10. Zargari A: Medicinal Plants, ed 4. Tehran, Tehran University Publications, 1997, pp 409-417.
11. Latti AK, Kainulainen PS, Hayirlioglu-Ayaz S, Ayaz FA, Riihinen R: Characterization of anthocyanins in Caucasian blueberries (Vaccinium arctostaphylos L.) native to Turkey. J Agric Food Chem 2009;57:5244-5249.
12. Abidov M, Ramazanov A, Jimenez Del Rio M, Chkhikvishvili I: Effect of blueberin on fasting glucose, C-reactive protein and plasma aminotransferases, in female volunteers with diabetes type 2: double-blind, placebo controlled clinical study. Georgian Med News 2006;141:66-72.
13. Kowalczyk E, Krzesinski P, Kura M, Szmigiel B, Blaszczyk J: Anthocyanins in medicine. Pol J Pharmacol 2003;55:699-702.
14. Ghosh D, Konishi T: Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr 2007;16:200-208.
15. Mazza GJ: Anthocyanins and heart health. Ann Ist Super Sanita 2007;43:369-374.
16. de Pascual-Teresa S, Moreno DA, Garcia-Viguera C: Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int J Mol Sci 2010;11:1679-1703.
17. Feshani AM, Kouhsari SM, Mohammadi S: Vaccinium arctostaphylos, a common herbal medicine in Iran: molecular and biochemical study of its antidiabetic effects on alloxan-diabetic Wistar rats. J Ethnopharmacol 2011;133:67-74.
18. Francis FJ: Analysis of anthocyanins; in Markakis P (ed): Anthocyanins as Food Colors. New York, Academic Press, 1982, pp 182-205.
19. Wiernsperger N, Rapin JR: Microvascular diseases: is a new era coming? Cardiovasc Hematol Agents Med Chem 2012;10:167-183.
20. Ayaz FA, Hayirlioglu-Ayaz S, Gruz J, Novak O, Strnad M: Separation, characterization, and quantitaion of phenolic acids in a little-known blueberry (Vaccinium arctostaphylos L.) fruit by HPLC-MS. J Agric Food Chem 2005;53:8116-8122.
21. Matsui T, Ebuchi S, Kobayashi M, Fukui K, Sugita K, Terahara N, Matsumoto K: Anti-hyperglycemic effect of diacylated anthocyanin derived from Ipomoea batatas cultivar Ayamurasaki can be achieved through the alpha-glucosidase inhibitory action. J Agric Food Chem 2002;50:7244-7248.
22. Van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM: Acute effects of decaffeinated coffee and the major coffee components chlorogenic acid and trigonelline on glucose tolerance. Diabetes Care 2009;32:1023-1025.
23. Ong KC, Khoo HE: Effects of myricetin on glycemia and glycogen metabolism in diabetic rats. Life Sci 2000;67:1695-1705.